Abstract:Purpose: The aim of this study was to evaluate the clinical value of simultaneous positron emission tomography/computed tomography (PET/CT) and abdominal positron emission tomography/magnet resonance imaging (PET/MRI) in the detection of liver metastases and extrahepatic disease (EHD) in patients with potentially resectable colorectal liver metastases (CLM). Methods: Fifty-six patients with CLM underwent conventional imaging (chest and abdomen CT, liver contrast-enhanced CT or MRI) and PET imaging [fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT and subsequent liver PET/MRI] for staging or restaging. Diagnostic ability of PET imaging was compared with conventional imaging. Abnormal findings were correlated with follow-up imaging and/or histology. The influence of the PET imaging findings was categorized for each patient in relation to operability and other significant findings. The clinical management included three modalities (surgery for resectable CLM, unresectable CLM with conversion treatment, and systemic therapy). The clinical impact of the imaging modality was analyzed. The operative histopathological analysis and/or imaging follow-up were performed as the standard of reference. Results: This study enrolled a total of 56 patients (median age 60 years, 62.5% were male, 36 with colon cancer and 20 with rectal cancer). For EHD detection, PET/CT detected more EHD than conventional imaging (60.7% vs. 46.4%). PET/CT had different findings in 19 (33.9%) patients, including downstaging in 4 (7.1%) patients and upstaging in 15 (26.8%) patients. For liver lesion detection, PET/MRI showed comparable detection ability with CE-MRI and CE-CT (99.5%, 99.4%, and 86.5%, respectively) based on lesion analysis, much higher than PET/CT (47.5%). PET imaging had a major impact in 10/56 (17.9%) patients (4 from unresectable to resectable, 6 from resectable to unresectable) and a minor impact in 4/56 (7.1%) patients for changing the surgery extent. The therapeutic strategies had been altered in a total of 14/56 patients (25%) after PET/CT and PET/MRI scans. Conclusion: The results of this study indicate that simultaneous 18F-FDG PET/CT and abdominal PET/MRI scans can provide accurate information regarding CLM status and EHD, and can affect the management of 25% of the patients by changing the therapeutic strategies determined by conventional imaging. This new modality may serve as a new one-stop method in patients with potentially resectable CLM.

Preoperative imaging evaluation for resectable colorectal liver metastasis

Imaging diagnosis of pancreatic cancer and preoperative imaging evaluation of resectability and staging

Preoperative prediction of hepatic blood flow and hepatic functional cell resecting ratio in patients with primary liver cancer

Role of imaging for patients with colorectal hepatic metastases: what the radiologist needs to know

The Value of 18F-FDG PET/CT and Abdominal PET/MRI as a One-Stop Protocol in Patients With Potentially Resectable Colorectal Liver Metastases

Preoperative CT and survival data for patients undergoing resection of colorectal liver metastases

Imaging Considerations before and after Liver-Directed Locoregional Treatments for Metastatic Colorectal Cancer

Role of contrast-enhanced ultrasound for preoperative detection of colorectal liver metastases-compared with histopathologic results

Therapeutic Effects of Hepatic Resection in Liver Metastasis of Colorectal Cancer

[Standard surgical resection of colorectal liver metastases]

Preoperative imaging of colorectal liver metastases: what the radiologist and the multidisciplinary team need to know

Metabolic Response to Preoperative Chemotherapy Predicts Prognosis for Patients Undergoing Surgical Resection of Colorectal Cancer Metastatic to the Liver

Perioperative Treatment Strategy for Colorectal Liver Metastases

Intraoperative (Contrast-Enhanced) Ultrasound Has the Highest Diagnostic Accuracy of Any Imaging Modality in Resection of Colorectal Liver Metastases

Preoperative Evaluation of Colorectal Liver Metastases: Comparison of Gadopentetate Dimeglumine and Gadoxetic-Acid-enhanced 1.5-T MRI

CT-based radiomics analysis to predict local progression of recurrent colorectal liver metastases after microwave ablation

[Surgical Treatment for Hepatic Metastases from Colorectal Carcinoma].

Prediction of Hepatic Lymph Node Metastases Based on Magnetic Resonance Imaging Before and after Preoperative Chemotherapy in Patients with Colorectal Liver Metastases Underwent Surgical Resection

Survival prediction in patients with resectable colorectal liver metastases: Clinical risk scores and tumor response to chemotherapy.

Prognosis of Radical Resection of Liver Metastases from Colorectal Cancer

The Role of the Multiparametric MRI LiverMultiScanTM in the Quantitative Assessment of the Liver and Its Predicted Clinical Applications in Patients Undergoing Major Hepatic Resection for Colorectal Liver Metastasis